Familial Hypercholesterolemia: A Patient Guide
At a Glance
Familial hypercholesterolemia is inherited high cholesterol caused by a gene change that limits the liver’s ability to clear cholesterol from the blood. Early diagnosis, family testing, healthy habits, and lifelong medical treatment help protect the heart.
Familial Hypercholesterolemia (FH) is a common but serious inherited condition that affects how the body manages cholesterol. Unlike typical high cholesterol, which often develops over time due to age or lifestyle, FH is caused by a genetic change that is present from the moment of birth [1]. This genetic mutation impairs the liver’s natural “filter,” known as the LDL-receptor pathway, which normally pulls extra cholesterol out of the bloodstream. Because this internal cleaning system does not work correctly, cholesterol levels can remain high even in individuals who are very active and follow a heart-healthy diet [2][3].
The condition exists on a spectrum, primarily categorized into two forms based on how the genes were inherited. The more common form, Heterozygous FH (HeFH), occurs when a person inherits one affected gene from one parent. The much rarer and more severe form, Homozygous FH (HoFH), happens when both parents pass on an affected gene, often leading to very high cholesterol levels starting in early childhood [4]. Regardless of the form, the persistent presence of extra cholesterol in the blood can lead to a gradual buildup in the arteries and heart valves, making early detection the single most important factor in long-term health [5].
Because FH is a family affair, a single diagnosis is often the key to protecting many lives. When one person is identified with FH, medical teams use a process called cascade testing to screen close biological relatives [6]. This proactive approach ensures that family members can start protective care as early as possible. While a healthy lifestyle remains a vital foundation for everyone and supports overall heart health, it is rarely enough to overcome the genetic “filter” problem on its own. Most people with FH will need medical interventions to manually lower their cholesterol to safe levels and prevent future heart issues [7].
Managing FH is a lifelong commitment, but it is one that is very well-supported by modern medicine. Today’s treatments are highly effective at mimicking the body’s natural filtering process, allowing people with FH to live long, active lives [8]. By working closely with a specialized care team, you can take control of your genetic risk and transform an invisible condition into a manageable part of a healthy future [5][9].
In this guide
6 chapters
Understanding Familial Hypercholesterolemia
Learn what familial hypercholesterolemia (FH) means, how LDLR, APOB, and PCSK9 mutations affect cholesterol, and why family screening and treatment matter.
Symptoms and Warning Signs of FH
Learn the warning signs of familial hypercholesterolemia, why children may have no visible symptoms, and when chest pain or fainting needs emergency care.
How FH is Diagnosed: Testing and Screening
Learn how familial hypercholesterolemia (FH) is diagnosed using LDL cholesterol, genetic testing, family history, and cascade screening for relatives.
The Roadmap to Treatment: A Stepwise Approach
Learn the stepwise treatment plan for familial hypercholesterolemia, including statins, ezetimibe, PCSK9 inhibitors, LDL-C goals, and lifelong heart protection.
Advanced Therapies for Severe and Homozygous FH
Learn about advanced treatments for homozygous familial hypercholesterolemia, including evinacumab, lomitapide, and lipoprotein apheresis, plus monitoring needs.
The Long View: Monitoring Your Heart Over a Lifetime
Learn how familial hypercholesterolemia affects lifelong heart risk, aortic valve health, Lp(a), risk scores, imaging choices, and emotional well-being.
Common questions in this guide
What is familial hypercholesterolemia, and how is it different from typical high cholesterol?
What is the difference between heterozygous and homozygous FH?
What does cascade testing mean for relatives with FH in the family?
Can diet and exercise control familial hypercholesterolemia by themselves?
What does lifelong treatment for FH aim to do?
Should children and other biological relatives be checked for FH?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific genetic mutation has been identified in my family, and how does it affect our liver's ability to clear cholesterol?
- 2.Which members of our extended family should be tested first, and what information do they need to provide to their own doctors?
- 3.How do we determine if I (or my child) have the heterozygous or homozygous form of this condition?
- 4.Since lifestyle changes alone are not enough for FH, what is our long-term plan for medical management?
- 5.Who else should be on our specialized care team—such as a pediatric cardiologist or a genetic counselor?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Molecular basis of familial hypercholesterolemia.
Bruikman CS, Hovingh GK, Kastelein JJP
Current opinion in cardiology 2017; (32(3)):262-266 doi:10.1097/HCO.0000000000000385.
PMID: 28169949 - 2
Familial Hypercholesterolemia: Global Burden and Approaches.
Tokgozoglu L, Kayikcioglu M
Current cardiology reports 2021; (23(10)):151 doi:10.1007/s11886-021-01565-5.
PMID: 34480646 - 3
Familial hypercholesterolemia.
Sawhney JPS, Madan K
Indian heart journal 2024; (76 Suppl 1()):S108-S112 doi:10.1016/j.ihj.2023.12.002.
PMID: 38599725 - 4
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Cuchel M, Raal FJ, Hegele RA, et al.
European heart journal 2023; (44(25)):2277-2291 doi:10.1093/eurheartj/ehad197.
PMID: 37130090 - 5
Familial hypercholesterolemia in children and the importance of early treatment.
van den Bosch SE, Hutten BA, Corpeleijn WE, Kusters DM
Current opinion in lipidology 2024; (35(3)):126-132 doi:10.1097/MOL.0000000000000926.
PMID: 38363694 - 6
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
Sturm AC, Knowles JW, Gidding SS, et al.
Journal of the American College of Cardiology 2018; (72(6)):662-680 doi:10.1016/j.jacc.2018.05.044.
PMID: 30071997 - 7
Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease.
Fahed AC, Wang M, Patel AP, et al.
JAMA network open 2022; (5(3)):e222687 doi:10.1001/jamanetworkopen.2022.2687.
PMID: 35294538 - 8
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
Luirink IK, Wiegman A, Kusters DM, et al.
The New England journal of medicine 2019; (381(16)):1547-1556 doi:10.1056/NEJMoa1816454.
PMID: 31618540 - 9
A Comprehensive Neuropsychological Study of Familial Hypercholesterolemia and Its Relationship with Psychosocial Functioning: A Biopsychosocial Approach.
Chan MF, Ganesh A, Mahadevan S, et al.
Brain sciences 2022; (12(9)) doi:10.3390/brainsci12091127.
PMID: 36138863
This page explains familial hypercholesterolemia for informational purposes and does not replace medical advice. Ask your clinician, cardiologist, or genetic counselor how the diagnosis and treatment plan apply to you and your family.
Get notified when new evidence is published on Familial hypercholesterolemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.